Skip to main content

Table 1 Baseline characteristics of the percutaneous radiofrequency thermal ablation (PRFA) and surgical resection (SR) patient groups

From: Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma

 

SR Group

(n = 69)

PRFA Group

(n = 162)

P value

Gender

   

   Male

50

95

0.054

   Female

19

67

 

Age

67.4 ± 9.7

68.4 ± 8.7

0.45

Tumor size (cm)

2.68 ± 0.49

1.9 9 ± 0.62

0.001

Etiology of liver disease

   

   chronic hepatitis B

8

9

0.182

   chronic hepatitis C

51

135

 

   non B, non C

10

18

 

Child-Pugh classification

   

   chronic hepatitis

19

35

0.285

   Child-Pugh A

45

102

 

   Child-Pugh B

5

22

 

   Child-Pugh C

0

3

 

Total-Bilirubin (mg/dL)

0.84 ± 0.48

0.93 ± 0.51

0.182

Serum albumin (g/dL)

3.89 ± 0.52

3.80 ± 0.55

0.248

Platelet ((×104/mm3)

13.4 ± 6.3

11.2 ± 4.8

0.004

AST (IU/L)

58.9 ± 39.7

59.6 ± 34.0

0.897

ALT (IU/L)

53.0 ± 38.8

51.1 ± 32.7

0.697

Prothrombin time (%)

89.9 ± 14.9

87.8 ± 15.0

0.35

AFP (ng/mL)

376.7 ± 1989.8

74.7 ± 181.1

0.056

PIVKAII (mAU/mL)

739.0 ± 3900.1

95.5 ± 154.2

0.037

  1. Data are expressed as the number of patients or the mean ± standard deviation. AST, aspartate aminotransferase; ALT, alanine aminotransferase; AFP, alpha-fetoprotein; PIVKAII, protein induced vitamin K absence or antagonist II